KAW letter to Intervet regarding their use of cefquinome pointing out that a majority of the Veterinary Medicine Advisory Committee (VMAC) found that the risk assessment prepared by their company did not demonstrate that cefquinome is safe with respect to the potential for transfer of antimicrobial resistant organisms to humans.